The Impact of COVID-19 is included in Remdesivir Market Report. Buy it today to get an advantage.
Request the impact of COVID-19 on your product or industry
Remdesivir Trends and Forecast
The future of the global remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets. The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030. The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.
A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.
Remdesivir by Segment
The study includes a forecast for the global remdesivir by dosage, form, application, distribution channel , and region.
Remdesivir Market by Dosage [Shipment Analysis by Value from 2018 to 2030]:
• 2.5MG
• 5MG
• 100MG
• 200MG
Remdesivir Market by Form [Shipment Analysis by Value from 2018 to 2030]:
• Lyophilized Powder
• Concentrated Solution
Remdesivir Market by Application [Shipment Analysis by Value from 2018 to 2030]:
• Ebola
• SARS-Cov
• MERS-Cov
Remdesivir Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:
• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
Remdesivir Market by Region [Shipment Analysis by Value from 2018 to 2030]:
• North America
• Europe
• Asia Pacific
• The Rest of the World
List of Remdesivir Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies remdesivir companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the remdesivir companies profiled in this report include-
• Jubilant Life Sciences
• Eva Pharma
• Pfizer
• Dr. Reddy’S Laboratories
• Viatris Pharmaceuticals
• Sun Pharmaceuticals Industries
• Gilead Sciences India Private
Remdesivir Market Insights
Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.
Within this market, hospital pharmacy will remain the largest segment due to prescription-only medication.
North America will remain the largest region over the forecast period due to the high prevalence of covid-19.
Features of the Global Remdesivir Market
Market Size Estimates: Remdesivir market size estimation in terms of value ($B).
Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
Segmentation Analysis: Remdesivir market size by various segments, such as by dosage, form, application, distribution channel , and region in terms of value ($B).
Regional Analysis: Remdesivir market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
Growth Opportunities: Analysis of growth opportunities in different dosage, form, application, distribution channel , and regions for the remdesivir market.
Strategic Analysis: This includes M&A, new product development, and competitive landscape of the remdesivir market.
Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQ
Q1. What is the growth forecast for remdesivir market?
Answer: The global remdesivir market is expected to grow with a CAGR of 7.0% from 2024 to 2030.
Q2. What are the major drivers influencing the growth of the remdesivir market?
Answer: The major drivers for this market are growing cases of viral infections and rise in unhygienic practices in rural areas, and rise in the need for prevention of viral infections.
Q3. What are the major segments for remdesivir market?
Answer: The future of the remdesivir market looks promising with opportunities in the hospital pharmacy, retail pharmacy, and online pharmacy markets.
Q4. Who are the key remdesivir market companies?
Answer: Some of the key remdesivir companies are as follows:
• Jubilant Life Sciences
• Eva Pharma
• Pfizer
• Dr. Reddy’S Laboratories
• Viatris Pharmaceuticals
• Sun Pharmaceuticals Industries
• Gilead Sciences India Private
Q5. Which remdesivir market segment will be the largest in future?
Answer: Lucintel forecasts that 100MG will remain the largest segment over the forecast period due to inhibiting the replication of the SARS-cov-2 virus.
Q6. In remdesivir market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to the high prevalence of covid-19.
Q7. Do we receive customization in this report?
Answer: Yes, Lucintel provides 10% customization without any additional cost.
This report answers following 11 key questions:
Q.1. What are some of the most promising, high-growth opportunities for the remdesivir market by dosage (2.5MG, 5MG, 100MG, and 200MG), form (lyophilized powder and concentrated solution), application (ebola, SARS-cov, and MERS-cov), distribution channel (hospital pharmacy, retail pharmacy, and online pharmacy), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?
For any questions related to Remdesivir Market, Remdesivir Market Size, Remdesivir Market Growth, Remdesivir Market Analysis, Remdesivir Market Report, Remdesivir Market Share, Remdesivir Market Trends, Remdesivir Market Forecast, Remdesivir Companies, write Lucintel analyst at email: helpdesk@lucintel.com. We will be glad to get back to you soon.
Table of Contents
1. Executive Summary
2. Global Remdesivir Market : Market Dynamics
2.1: Introduction, Background, and Classifications
2.2: Supply Chain
2.3: Industry Drivers and Challenges
3. Market Trends and Forecast Analysis from 2018 to 2030
3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
3.2. Global Remdesivir Market Trends (2018-2023) and Forecast (2024-2030)
3.3: Global Remdesivir Market by Dosage
3.3.1: 2.5MG
3.3.2: 5MG
3.3.3: 100MG
3.3.4: 200MG
3.4: Global Remdesivir Market by Form
3.4.1: Lyophilized Powder
3.4.2: Concentrated Solution
3.5: Global Remdesivir Market by Application
3.5.1: Ebola
3.5.2: SARS-COV
3.5.3: MERS-COV
3.6: Global Remdesivir Market by Distribution Channel
3.6.1: Hospital Pharmacy
3.6.2: Retail Pharmacy
3.6.3: Online Pharmacy
4. Market Trends and Forecast Analysis by Region from 2018 to 2030
4.1: Global Remdesivir Market by Region
4.2: North American Remdesivir Market
4.2.2: North American Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.3: European Remdesivir Market
4.3.1: European Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
4.3.2: European Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.4: APAC Remdesivir Market
4.4.1: APAC Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
4.4.2: APAC Remdesivir Market by Distribution Channel : Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
4.5: ROW Remdesivir Market
4.5.1: ROW Remdesivir Market by Dosage: 2.5MG, 5MG, 100MG, and 200MG
4.5.2: ROW Remdesivir Market by Distribution Channel: Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy
5. Competitor Analysis
5.1: Product Portfolio Analysis
5.2: Operational Integration
5.3: Porter’s Five Forces Analysis
6. Growth Opportunities and Strategic Analysis
6.1: Growth Opportunity Analysis
6.1.1: Growth Opportunities for the Global Remdesivir Market by Dosage
6.1.2: Growth Opportunities for the Global Remdesivir Market by Form
6.1.3: Growth Opportunities for the Global Remdesivir Market by Application
6.1.4: Growth Opportunities for the Global Remdesivir Market by Distribution Channel
6.1.5: Growth Opportunities for the Global Remdesivir Market by Region
6.2: Emerging Trends in the Global Remdesivir Market
6.3: Strategic Analysis
6.3.1: New Product Development
6.3.2: Capacity Expansion of the Global Remdesivir Market
6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Remdesivir Market
6.3.4: Certification and Licensing
7. Company Profiles of Leading Players
7.1: Jubilant Life Sciences
7.2: Eva Pharma
7.3: Pfizer
7.4: Dr. Reddy’s Laboratories
7.5: Viatris Pharmaceuticals
7.6: Sun Pharmaceuticals Industries
7.7: Gilead Sciences India Private
.
Buy full report or by chapter as follows
Lucintel has been in the business of market research and management consulting since 2000 and has published over 1000 market intelligence reports in various markets / applications and served over 1,000 clients worldwide. This study is a culmination of four months of full-time effort performed by Lucintel's analyst team. The analysts used the following sources for the creation and completion of this valuable report:
In-depth interviews of the major players in this market
Detailed secondary research from competitors’ financial statements and published data
Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
A compilation of the experiences, judgments, and insights of Lucintel’s professionals, who have analyzed and tracked this market over the years.
Extensive research and interviews are conducted across the supply chain of this market to estimate market share, market size, trends, drivers, challenges, and forecasts. Below is a brief summary of the primary interviews that were conducted by job function for this report.
Thus, Lucintel compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. Lucintel then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process. The figure below is a graphical representation of Lucintel’s research process.
Please sign in below to get report brochure - Remdesivir Market Report.